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Background: The prognostic role of NT-proBNP in asymptomatic subjects at high cardiovascular risk and no history of cardiac disease is unknown. 
The aim of the present study was to assess the predictive value of NT-pro BNP in a large cohort of subjects with hypertension and diabetes from 
primary care, where a 5.1% prevalence of asymptomatic left ventricular dysfunction had been previously assessed by echocardiography.
Methods: 1012 asymptomatic subjects (mean age 66.4 ± 7.8 years, 48% males) with hypertension and/or diabetes and no history of cardiac 
disease, randomly extracted from a general practitioners` database, were assessed by NT-proBNP assay. Patients were followed up for the 
development of major adverse cardiovascular events (MACE) defined as acute coronary syndrome, heart failure requiring hospitalization and 
cardiovascular death.
Results: During a follow-up of 38.5 ± 4.1 months, MACE occurred in 63 patients. At Cox regression analysis independent predictors of MACE were: 
NT-proBNP (100-149 pg/mL: HR 2.65, 95% CI 1.31-5.37, P<0.01; >150 pg/mL: HR 4.36, 95% CI 2.38-8.01, P<0.0001), echocardiographic left 
ventricular systolic dysfunction (HR 3.60, 95% CI 1.38-9.37, P<0.01), diabetes (HR 2.57, 95% CI 1.53-4.32, P<0.0001) and male gender (HR 2.04, 
95% CI 1.19-3.44, P<0.01).
Conclusions: NT-pro BNP is an independent predictor of cardiovascular events in asymptomatic subjects at high risk of cardiovascular disease. As 
a >150 pg/mL NT-pro BNP value in asymptomatic diabetic and/or hypertensive patients identifies a subgroup at high risk of cardiovasuclar events, 
this might alert primary care physicians to watchfully investigate their patients.
